These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11770280)

  • 61. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA; Amonkar MM; Hebborn A; Altman R
    Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622
    [No Abstract]   [Full Text] [Related]  

  • 63. Glucocorticoid-induced osteoporosis: treatment options and guidelines.
    Maricic M
    Curr Osteoporos Rep; 2005 Mar; 3(1):25-9. PubMed ID: 16036098
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.
    Geusens P
    Curr Osteoporos Rep; 2009 Mar; 7(1):12-7. PubMed ID: 19239824
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Diphosphonates in the treatment of osteoporosis].
    Papapoulos SE; Lockefeer JH
    Ned Tijdschr Geneeskd; 1991 Mar; 135(13):553-6. PubMed ID: 1902912
    [No Abstract]   [Full Text] [Related]  

  • 66. Bisphosphonates in the treatment of osteoporosis.
    Hochberg MC
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):53S-55S. PubMed ID: 9273939
    [No Abstract]   [Full Text] [Related]  

  • 67. Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Weryha G; Marques-Neto JF; Gaines KA; Verbruggen N; Melton ME
    Clin Drug Investig; 2006; 26(2):63-74. PubMed ID: 17163237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Absolute vs. relative numbers in evaluating drug therapy.
    McCormack J
    Am Fam Physician; 2001 May; 63(10):1913-4, 1916. PubMed ID: 11388707
    [No Abstract]   [Full Text] [Related]  

  • 71. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.
    Hodsman AB; Hanley DA; Josse R
    CMAJ; 2002 May; 166(11):1426-30. PubMed ID: 12054412
    [No Abstract]   [Full Text] [Related]  

  • 72. Risedronate therapy for prevention of hip fracture after stroke in elderly women.
    Poole KE; Warburton EA; Reeve J
    Neurology; 2005 Nov; 65(9):1513-4; author reply 1513-4. PubMed ID: 16275859
    [No Abstract]   [Full Text] [Related]  

  • 73. Prevention and treatment of osteoporosis.
    Prestwood KM; Raisz LG
    Clin Cornerstone; 2000; 2(6):34-44. PubMed ID: 10938990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate.
    Harris ST
    Osteoporos Int; 2001 Dec; 12 Suppl 3():S11-6. PubMed ID: 11846336
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Osteoporosis: which current treatments reduce fracture risk?
    Baran DT
    Cleve Clin J Med; 2000 Oct; 67(10):701-3. PubMed ID: 11060956
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 77. Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment.
    Iba K; Takada J; Hatakeyama N; Ozasa Y; Wada T; Yamashita T
    J Orthop Sci; 2008 Sep; 13(5):438-41. PubMed ID: 18843458
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A tale of two worlds in prescribing etidronate for osteoporosis.
    Rosen CJ
    Lancet; 1997 Nov; 350(9088):1340. PubMed ID: 9365446
    [No Abstract]   [Full Text] [Related]  

  • 79. Prevention and treatment of osteoporosis.
    Prestwood KM; Raisz LG
    Clin Cornerstone; 2002; 4(6):31-41. PubMed ID: 12739329
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
    Drake WM; Kendler DL; Brown JP
    Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.